Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 4A1 pseudogene 5 (EIF4A1P5) is a non-coding DNA sequence in the human genome classified as a pseudogene, meaning it is a genomic sequence similar to the functional EIF4A1 gene but generally does not produce a functional protein. There is no evidence supporting a direct biological function, disease association, or drug interaction for EIF4A1P5. Its designation as a pseudogene distinguishes it from EIF4A1, which is an active ATP-dependent RNA helicase essential for mRNA translation initiation[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 4A1 pseudogene 5 (EIF4A1P5).